Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis

Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis

Background: The aim of the study was to systematically evaluate and compare the efficacy of everolimus-eluting stents (EESs) and paclitaxel-coated balloons (PCBs) in treating patients with in-stent restenosis (ISR). Methods:...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhili Wei, Ziran Luo, Yixvan Chang, Zhijing An, Sai Jin, Jianke Rong, Bing Song
Format:	Article
Language:	English
Published:	IMR Press 2025-06-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	in-stent restenosis paclitaxel-coated balloon everolimus-eluting stent systematic review/meta-analysis
Online Access:	https://www.imrpress.com/journal/RCM/26/6/10.31083/RCM26387
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01)

Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01)

Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Drug-coated balloon in patients with in-stent restenosis: A prospective observational study
by: Shuvanan Ray, et al.
Published: (2025-03-01)

Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Birong Liu, et al.
Published: (2024-12-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
by: V. P. Lupanov, et al.
Published: (2009-10-01)

Clinical Significance of Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for In‐Stent Restenosis Within Drug‐Eluting Stents: Impact on Patient Outcomes
by: Yan Han, et al.
Published: (2024-11-01)

Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01)

Recent Advances in the Treatment of Coronary In-Stent Restenosis
by: Luca Sartore, et al.
Published: (2024-12-01)

Stent Failure Management in Contemporary Clinical Practice
by: Iosif Xenogiannis, et al.
Published: (2025-07-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

Monocyte to high-density lipoprotein cholesterol ratio predicts restenosis of drug-eluting stents in patients with unstable angina pectoris
by: He Meng, et al.
Published: (2024-12-01)

Fabrication of a 3D printed everolimus-eluting stent made of thermoplastic polyurethane and polylactide
by: M. T. Bekov, et al.
Published: (2024-04-01)

Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease
by: Hesham Refaat, et al.
Published: (2025-07-01)

Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty vs. stenting for the treatment of acute thrombotic and critical limb ischaemia in the femoropopliteal segment
by: Paweł Latacz, et al.
Published: (2018-11-01)

Safety and efficacy of Evermine50 Everolimus-eluting coronary stent system in patients with native coronary artery lesions: Three-year outcomes from a single-center
by: Suresh V Patted
Published: (2025-03-01)

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
by: Hui Wang, et al.
Published: (2024-12-01)

Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Hotmauli Siahaan, et al.
Published: (2025-07-01)

Stent-induced hypersensitivity leading to refractory in-stent restenosis: a case report
by: Menghuai Ma, et al.
Published: (2025-03-01)

Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis
by: Ahmed Abdelaziz, et al.
Published: (2025-04-01)

Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents
by: Xi Wu, et al.
Published: (2025-07-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
by: Jianbing Zhang, et al.
Published: (2025-01-01)

Pre‐Percutaneous Coronary Intervention C‐Reactive Protein Levels and In‐Stent Restenosis: A Systematic Review and Meta‐Analysis
by: Himanshu Rai, et al.
Published: (2025-05-01)

The predictive value of preprocedural laboratory data in patients with coronary artery restenosis in various types of stents
by: D. V. Shames, et al.
Published: (2019-04-01)

Drug‐Coated Balloons in In‐Stent Restenosis, a New Standard of Care or Yesterday's News?
by: Nicholas Weight, et al.
Published: (2024-12-01)

Exploring the Role of Stent Strut Geometry in Cellular Behavior: An In Vitro Chip Model to Understand In‐Stent Restenosis
by: Emmie J.D. Schoutens, et al.
Published: (2025-08-01)

Management of in-stent restenosis after iliofemoral venous stenting
by: XU Huimin, GAO Hongxia
Published: (2024-11-01)

Comparing Patency of Pulmonary Stent Implantation and Balloon Angioplasty in Pulmonary Vein Stenosis: A Systematic Review and Meta‐Analysis
by: Izza Batool, et al.
Published: (2025-01-01)

Reestenosis de stents liberadores de paclitaxel frente a stents convencionales
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01)

Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease
by: Yingkun Chen, et al.
Published: (2025-05-01)

Is there enough evidence for routine use of drug-eluting stents in acute myocardial infarction with ST segment elevation?
by: Tešić Milorad, et al.
Published: (2014-01-01)

A Strategy for the In-Silico Assessment of Drug Eluting Stents: A Comparative Study for the Evaluation of Retinoic Acid as a Novel Drug Candidate for Drug Eluting Stents
by: Dimitrios S. Pleouras, et al.
Published: (2025-01-01)